🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

EFFECTIVITY OF CHITOSAN COVERED GAUZE IN POSTPARTUM HEMORRHAGIC OBSTETRIC LACERATIONS

RecruitingNAAges 18 Years - 48 YearsFemaleIstanbul Training and Research Hospital
NCT06998641 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study was planned to investigate the efficacy of different treatment methods that can be used in the treatment of hemorrhagic tears that may occur in the postpartum period. The volunteers who will participate in the study will be evaluated during the hospitalization period after delivery and at the end of the puerperium 6 weeks after delivery, in accordance with routine postpartum control examinations. In the treatment of postpartum hemorrhagic tears, the treatment options such as suturing the tears to stop bleeding or applying tampons with bleeding stopping agent (chitosan) and compression effect to the torn area will be determined completely randomly.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Women who delivered at the Department of Obstetrics and Gynecology of Istanbul Training and Research Hospital between March 2025 and March 2027. * Age between 18 and 48 years. * Presence of a bleeding postpartum obstetric laceration (first- or second-degree) without an anatomical defect requiring surgical repair. * Absence of additional conditions that may affect the amount of postpartum bleeding, such as uterine atony or retained placental tissue. * Provision of written informed consent for participation in the study. Exclusion Criteria: * Age younger than 18 years or older than 48 years. * Absence of a bleeding postpartum first- or second-degree obstetric laceration meeting the study criteria. * Presence of an obstetric laceration with an anatomical defect requiring surgical repair. * Presence of additional causes or conditions that may affect postpartum blood loss, such as uterine atony or retained placental tissue. * Failure to provide informed consent.
💊

What it tests

  • Chitosan-covered-gauze application
  • Suturation
📍

Where

1 site
Istanbul Training and Research Hospital Department of Obstetrics and Gynecology
Istanbul, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy